UCSD Study: Cannabis affects childhood brain development, ‘real risk’ for teens – Times of San Diego
#78 Strong Clinical Relevance
High-quality evidence with meaningful patient or clinical significance.
Clinicians should counsel adolescent patients and parents that cannabis use during critical developmental periods can impair attention, processing speed, and memory formation, which may have lasting consequences for academic performance and cognitive function. This evidence supports clinical screening for cannabis use in teenage patients and provides a data-driven foundation for preventive counseling during routine visits.
Researchers at UC San Diego have identified significant associations between cannabis use during adolescence and alterations in brain development, particularly in neural regions governing attention, processing speed, and memory consolidation. The study adds to mounting evidence that the adolescent brain, which continues developing into the mid-20s, appears uniquely vulnerable to cannabis’s neurotoxic effects compared to adult users. These findings have direct clinical implications for physicians counseling adolescent patients and their families about substance use risks, as cognitive deficits in attention and information retention could impact academic performance, decision-making capacity, and long-term outcomes. The research underscores the importance of screening for cannabis use in pediatric and adolescent populations and incorporating age-specific risk discussions into preventive care visits. Clinicians should emphasize to teenage patients and parents that cannabis poses a “real risk” to developing brain function and recommend evidence-based interventions for youth already using cannabis to prevent further neurodevelopmental compromise.
“What this research confirms clinically is what I’ve observed over two decades: adolescent cannabis use during critical neurodevelopmental windows creates measurable deficits in attention and working memory that don’t simply resolve when use stops. Parents need to understand this isn’t about moral judgment but about basic neurobiology, and teenagers deserve straightforward information about genuine developmental risks during the exact years their brains are building executive function.”
? This UCSD research adds to growing evidence that cannabis exposure during adolescence may disrupt critical neurodevelopmental processes, particularly attention and memory function, at a time when the prefrontal cortex is still maturing. While the study contributes meaningful data, clinicians should note that establishing causality in developmental neuroscience is complex, with confounders such as concurrent substance use, genetic predisposition, socioeconomic factors, and underlying psychiatric conditions difficult to fully disentangle. The findings are particularly relevant given increasing youth access to high-potency cannabis products and changing legal status in many states, which may alter adolescents’ risk perception. In practice, this evidence supports screening for cannabis use during adolescent visits and counseling patients and families about potential cognitive risks, while recognizing that motivations for use are often multifactorial and require a non-judgmental, motivational approach rather than fear-based messaging alone.
This topic comes up in consultations often.
Dr. Caplan offers clinical context on evolving cannabis policy and its real-world implications for patients.
Book a consultation →💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
